In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells. Of interest to researchers is the potential for use of stem cells in regenerative medicine to treat conditions ranging from diabetes, to cardiovascular disease and neurological disorders. Additionally, the ability to use stem cells to improve drug target validation and toxicology screening is of intense interest to pharmaceutical companies. Stem cells are also being studied for their ability to improve both the understanding and treatment of birth disorders.

To facilitate research resulting from interest in these far-ranging applications, a large and growing stem cells research products market has emerged. Large companies selling stem cell research products include Invitrogen, BD Biosciences, Thermo Fisher Scientific, and Millipore, although dozens of other suppliers exist as well. Products offered by these companies include: antibodies to stem cell antigens, bead-based stem cell separation systems, stem cell protein purification and analysis tools, tools for DNA and RNA-based characterization of stem cells, stem cell culture and media reagents, stem cell specific growth factors and cytokines, tools for stem cell gene regulation, a range of stem cell services, tools for in vivo and in vitro stem cell tracking, and stem cell lines.

Currently, the federal government is an important, although not dominant, source of funding for stem cell research. The reason is that states are spending almost as much as the federal government on stem cell research and are actually spending more than the federal government on human embryonic stem cell (hESC) research. Private sources also contribute a huge about of funding, with analysis of recent large gifts summing to over $1.7 billion.

Specifically, market analysis determined the size of the stem cell research products market to be $883M and growing at a rate of 8.9% for full-year 2010. As growth of the stem cell research market is best modeled by polynomial growth, the size of the market is predicted to increase to $1.35B by 2015.

Because of the massive size of this market, developing either niche products or a diverse stem cell product line represents a significant opportunity for research supply companies. This report explores current market conditions and provides guidance for companies interested in developing strategically positioned stem cell product lines.

Market Report Overview: Stem Cell Research Products

Table of Contents: Stem Cell Research Products

View Sample

* Customers purchasing the report prior to Feb 10th, 2012, at 11:59pm EST, will receive a free Apple iPad 2 mailed to them at the time of purchase. For these customers, a modified 60-Day Guarantee is in effect, in which the client may receive a maximal refund percent of 75% of the purchase price, to cover the costs of the Apple iPad 2. The offer for a free Apple iPad 2 is available to clients in all countries, although the client is responsible for duty taxes that may arise from international shipment. BioInformant will provide evidence of shipment, but is not responsible for possible loss or damage of the item during delivery.

No confirmation is necessary during check-out for free Apple iPad 2 to be issued. Fulfillment is automatic for all purchases placed prior to Feb 10th, 2012 at 11:59pm EST.

** All major international currencies accepted.
*** Companies may inquire about a small business discount, or "Price and Slice" options, by emailing info@bioinformant.com.

(Phone) 703-859-7617       info@bioinformant.com       (Fax) 614-352-2369

Copyright © 2012 BioInformant Worldwide, L.L.C. All rights reserved.